Network Bio launches with $50m for biological AI

Human tissue, longitudinal outcomes and multimodal data underpin a new platform seeking transferable signals across disease. Network Bio has launched with $50 million in financing to expand an AI platform built around large-scale human biological datasets, combining patient-derived tissue and paired blood samples with molecular information and longitudinal clinical outcomes. Investors include Section 32, Thiel […] The post Network Bio launches with $50m for biological AI appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.